VENUS REMEDIES LTD.
BSE: 526953
Revenue & Profit Trend
in croresMargin Trend
percentage| Period | Q1 FY27 | Q4 FY26 | Q3 FY26 | Q2 FY26 | Q1 FY26 | Q4 FY25 | Q3 FY25 | Q2 FY25 |
|---|---|---|---|---|---|---|---|---|
| INCOME | ||||||||
| Revenue | 178.80-31.0% | 259.01+43.9% | 179.95-6.6% | 192.65+46.1% | 131.85-32.1% | 194.04+12.5% | 172.54+3.3% | 167.02 |
| Other Income | 2.55-45.0% | 4.64+92.5% | 2.41+43.5% | 1.68-79.0% | 8.00+18.2% | 6.77+289.1% | 1.74-83.8% | 10.71 |
| Total Income | 181.35-31.2% | 263.65+44.6% | 182.36-6.2% | 194.33+39.0% | 139.85-30.4% | 200.81+15.2% | 174.28-1.9% | 177.73 |
| EXPENSES | ||||||||
| Expenditure | 148.75-27.8% | 206.07+37.8% | 149.55-11.4% | 168.73+34.8% | 125.15-28.9% | 175.98+13.7% | 154.83-5.0% | 162.92 |
| Tax | 7.07-49.9% | 14.11+78.8% | 7.89+24.1% | 6.36+111.3% | 3.01-57.7% | 7.11+34.7% | 5.28-4.9% | 5.55 |
| PROFIT | ||||||||
| PBT | 32.60-43.4% | 57.58+75.5% | 32.81+28.2% | 25.60+74.1% | 14.70-40.8% | 24.83-15.4% | 29.36+98.2% | 14.81 |
| Net Profit | 25.53-41.3% | 43.47+74.4% | 24.92+29.5% | 19.24+64.6% | 11.69-21.0% | 14.79-38.6% | 24.08+160.0% | 9.26 |
| KEY METRICS | ||||||||
| OPM % | 20.45%-2.50pp | 22.95%+2.54pp | 20.41%+4.92pp | 15.49%+5.90pp | 9.59%-2.03pp | 11.62% | — | — |
| NPM % | 14.08%-2.41pp | 16.49%+2.82pp | 13.67%+3.77pp | 9.90%+1.54pp | 8.36%+0.99pp | 7.37%-6.45pp | 13.82%+8.61pp | 5.21% |
| EPS | 19.10-41.2% | 32.51+74.4% | 18.64+29.4% | 14.40+64.6% | 8.75-21.0% | 11.07-38.6% | 18.02+160.4% | 6.92 |
Corporate Events
Board Meeting
The 37th Annual General Meeting of the Company is scheduled …
BSE Filing ↗Board Meeting
The meeting of the Board of Directors is scheduled to be hel…
BSE Filing ↗Board Meeting
The 17th Annual General Meeting (AGM) of the members of Home…
BSE Filing ↗Board Meeting
The board meeting is scheduled to consider and approve audit…
BSE Filing ↗Board Meeting
Consider and approve Unaudited Standalone and Consolidated F…
BSE Filing ↗Board Meeting
Considering and approving Unaudited Standalone and Consolida…
BSE Filing ↗Board Meeting
Considering and approving the Unaudited Standalone and Conso…
BSE Filing ↗Board Meeting
Consideration of appointment of independent director, finali…
BSE Filing ↗Board Meeting
To consider and approve Audited Standalone and Consolidated …
BSE Filing ↗Board Meeting
Consider and approve Unaudited Standalone and Consolidated F…
BSE Filing ↗